search
Back to results

Birth Experience During COVID-19 Confinement (CONFINE)

Primary Purpose

Postpartum Depression

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Self-administered questionnaires
Sponsored by
Central Hospital, Nancy, France
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional screening trial for Postpartum Depression focused on measuring confinement, birth experience, covid-19

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Woman who is >= 18 years old
  • Woman having just given birth from 37 weeks of gestation (singleton pregnancy)
  • Woman affiliated to a social security
  • Woman with a level of understanding of written French sufficient to answer the questionnaires.
  • Woman having received complete information on the organization of the research and having given her informed consent in written form.

Specific inclusion criteria according to the group For "confinement"group : Delivery during covid-19 confinement period

For "epidemic" group: Delivery after confinement period and before the withdrawal of sanitary measures implemented (mask, social distancing, limited visits during post-partum immediate)

For "control" group: Start of pregnancy after confinement and delivery after the withdrawal of all sanitary measures (mask, social distancing, limited visits during post-partum immediate)

Exclusion Criteria:

  • Major mentioned in articles L.1121-6 and L-1121-8 of Health Public Code.
  • Woman with psychiatric disorders such as depressive syndrome
  • Woman considered positive for covid-19 and treated as such at the time of delivery (regardless of test result)
  • Newborn with congenital abnormalities
  • Stillbirth

Sites / Locations

  • Centre Hospitalier Régional Universitaire de NancyRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Other

Other

Arm Label

Confinement group

Control group

Epidemic group

Arm Description

Delivery during covid-19 confinement period

Delivery after the withdrawal of all sanitary measures (mask, social distancing, limited visits during post-partum immediate)

Delivery after confinement period and before the withdrawal of sanitary measures implemented (mask, social distancing, limited visits during post-partum immediate)

Outcomes

Primary Outcome Measures

"Labor Agentry Scale questionnaire" score in immediate post-partum (duration of hospital stay)

Secondary Outcome Measures

"Labor Agentry Scale questionnaire" score at two months after birth
Edinburg Postnatale Depression Scale questionnaire" score at two months after birth
To detect suspicion of Post-Partum Depression
"Impact of Event Scale - Revised questionnaire" score at two months after birth
To detect suspicion of Post traumatic stress syndrome
Breastfeeding statement at two months after birth
"SF-12 Quality of life questionnaire" score at two months after birth
"SF-12 Quality of life questionnaire" score in immediate post-partum
Diagnosis of post-natal depression (made by a specialist)

Full Information

First Posted
April 10, 2020
Last Updated
February 6, 2023
Sponsor
Central Hospital, Nancy, France
search

1. Study Identification

Unique Protocol Identification Number
NCT04348929
Brief Title
Birth Experience During COVID-19 Confinement
Acronym
CONFINE
Official Title
Birth Experience During COVID-19 Confinement (Confinement and Fostering Intrapartum Care)
Study Type
Interventional

2. Study Status

Record Verification Date
February 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 16, 2020 (Actual)
Primary Completion Date
August 16, 2023 (Anticipated)
Study Completion Date
October 1, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Central Hospital, Nancy, France

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Different studies have demonstrated that the absence of companionship during labor and childbirth may be responsible for a negative birth experience, an increased risk of postnatal depression and/or post traumatic stress disorders. These situation may also have a negative impact on mother-child interaction, on marital and family relationship and on the rate of maternal suicide in postpartum. However, these previous results cannot be extrapolated in the current context where the absence of the companionship is imposed by the confinement framework. The objective of the CONFINE study is to assess, for the first time, the birth experience of women in the context of limited social support in the immediate post-partum period due to confinement, as well as the associated over-risk of mental disorders, compared to a post-partum without social restriction.
Detailed Description
The primary objective is to compare, in immediate post-partum, the maternal sense of control during childbirth between a group of women who gave birth during confinement ("confinement" group) versus a group of women who gave birth after confinement but in the context of epidemic ("epidemic" group) versus a group of control women ("control" group; excluding confinement and context of epidemic). The secondary objectives are: To compare, at two months post-partum, the maternal sense of control during childbirth between the three groups. To compare, at two months of post-partum, scoring of self-questionnaire Edinburg Postnatale Depression Scale (EPDS) for the post-natal depression between the three groups. To compare at two months of post-partum, scoring of self-questionnaire Impact of Event Scale - Revised (IES-R) for posttraumatic stress disorder, between the three groups. To compare, at two months of post-partum, the breastfeeding between the three groups. To compare, at two months of post-partum, the quality of life (SF-12) between the three groups. To compare the evolution of quality of life at two months of post-partum between the three groups. To compare the rate of post-natal depression between the three groups.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postpartum Depression
Keywords
confinement, birth experience, covid-19

7. Study Design

Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
927 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Confinement group
Arm Type
Experimental
Arm Description
Delivery during covid-19 confinement period
Arm Title
Control group
Arm Type
Other
Arm Description
Delivery after the withdrawal of all sanitary measures (mask, social distancing, limited visits during post-partum immediate)
Arm Title
Epidemic group
Arm Type
Other
Arm Description
Delivery after confinement period and before the withdrawal of sanitary measures implemented (mask, social distancing, limited visits during post-partum immediate)
Intervention Type
Other
Intervention Name(s)
Self-administered questionnaires
Intervention Description
Self-administered questionnaires once during the post-natal hospitalization and a second time 7 to 9 weeks after the delivery (at home)
Primary Outcome Measure Information:
Title
"Labor Agentry Scale questionnaire" score in immediate post-partum (duration of hospital stay)
Time Frame
through study completion, an average of 16 months
Secondary Outcome Measure Information:
Title
"Labor Agentry Scale questionnaire" score at two months after birth
Time Frame
through study completion, an average of 16 months
Title
Edinburg Postnatale Depression Scale questionnaire" score at two months after birth
Description
To detect suspicion of Post-Partum Depression
Time Frame
through study completion, an average of 16 months
Title
"Impact of Event Scale - Revised questionnaire" score at two months after birth
Description
To detect suspicion of Post traumatic stress syndrome
Time Frame
through study completion, an average of 16 months
Title
Breastfeeding statement at two months after birth
Time Frame
through study completion, an average of 16 months
Title
"SF-12 Quality of life questionnaire" score at two months after birth
Time Frame
through study completion, an average of 16 months
Title
"SF-12 Quality of life questionnaire" score in immediate post-partum
Time Frame
through study completion, an average of 16 months
Title
Diagnosis of post-natal depression (made by a specialist)
Time Frame
through study completion, an average of 16 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Woman who is >= 18 years old Woman having just given birth from 37 weeks of gestation (singleton pregnancy) Woman affiliated to a social security Woman with a level of understanding of written French sufficient to answer the questionnaires. Woman having received complete information on the organization of the research and having given her informed consent in written form. Specific inclusion criteria according to the group For "confinement"group : Delivery during covid-19 confinement period For "epidemic" group: Delivery after confinement period and before the withdrawal of sanitary measures implemented (mask, social distancing, limited visits during post-partum immediate) For "control" group: Start of pregnancy after confinement and delivery after the withdrawal of all sanitary measures (mask, social distancing, limited visits during post-partum immediate) Exclusion Criteria: Major mentioned in articles L.1121-6 and L-1121-8 of Health Public Code. Woman with psychiatric disorders such as depressive syndrome Woman considered positive for covid-19 and treated as such at the time of delivery (regardless of test result) Newborn with congenital abnormalities Stillbirth
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Charline BERTHOLDT
Phone
+3383344312
Email
c.bertholdt@chru-nancy.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Charline BERTHOLDT
Organizational Affiliation
Centre Hospitalier Régional Universitaire de Nancy
Official's Role
Study Chair
Facility Information:
Facility Name
Centre Hospitalier Régional Universitaire de Nancy
City
Nancy
ZIP/Postal Code
54000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Charline BERTHOLDT
Email
c.bertholdt@chru-nancy.fr

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
All data generated during this study will be made available via CIC-EC, CHRU Nancy, Nancy- FRANCE in accordance with protocol promotor. Data obtained from this study will be deposited at CIC-EC Nancy where they will be maintained for a minimum of 15 years.
Citations:
PubMed Identifier
33303470
Citation
Bertholdt C, Epstein J, Banasiak C, Ligier F, Dahlhoff S, Olieric MF, Mottet N, Beaumont M, Morel O. Birth experience during COVID-19 confinement (CONFINE): protocol for a multicentre prospective study. BMJ Open. 2020 Dec 10;10(12):e043057. doi: 10.1136/bmjopen-2020-043057.
Results Reference
derived

Learn more about this trial

Birth Experience During COVID-19 Confinement

We'll reach out to this number within 24 hrs